Datwin, Baby Boy .
HRN: 21-39-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2022
AMPICILLIN 250MG (VIAL)
06/26/2022
07/04/2022
IV
950mg
Q12h
Potentially Septic Newborn
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes